VHOSPITAL.CLINIC · Parasite Treatment Drug
Albendazole is the essential medical component of echinococcosis treatment — used perioperatively, as PAIR adjunct therapy, or as sole treatment for inoperable cysts.
Albendazole sulphoxide penetrates the outer laminated membrane of hydatid cysts and accumulates in cyst fluid. It inhibits tubulin polymerisation in protoscoleces and germinal layer cells, reducing cyst viability and preventing daughter cyst formation.
Standard: 400 mg twice daily with fatty food in 28-day cycles, alternating with 14-day rest periods (reduces hepatotoxicity). Pre- and post-surgical: at least 4 days before and 1 month after intervention. Continuous treatment increasingly used.
This is a general reference. Always follow your physician's prescription and local treatment guidelines.
In selected cases (small CE1/CE3a cysts, <5 cm), albendazole monotherapy achieves parasitological cure in 30–40% of cases. PAIR (Percutaneous Aspiration Injection Re-aspiration) combined with albendazole is more effective than either alone.
Cyclic therapy (28 days on, 14 days off) was traditional to reduce hepatotoxicity. However, cyst fluid albendazole concentrations drop during rest periods. Continuous treatment is increasingly preferred with monthly liver monitoring.
Duration depends on cyst status. Surgical patients: minimum 4 days pre-op + 1–3 months post-op. Medical-only treatment: at least 3–6 months, often years for CE4/CE5 or multiple cysts. WHO staging guides duration.
Albendazole treats Echinococcosis (Hydatid Disease), which can cause these symptoms:
Explore our medical library for comprehensive treatment protocols, drug comparisons, prevention strategies, and resistance patterns.
Get a structured AI clinical assessment — possible parasitic causes, red flags, and next steps based on your symptoms.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: